文献速递性腺与生殖内分泌

多囊卵巢综合征与哮喘之间的基因组相关性、共享位点及药物靶点:基于全基因组关联分析的见解

Genomic Correlations, Shared Loci, and Drug Targets Between Polycystic Ovary Syndrome and Asthma: Insights From Genome-wide Association Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究整合UK Biobank与FinnGen队列中10 074例多囊卵巢综合征(PCOS)病例及哮喘相关性状数据,分析遗传架构。发现PCOS与哮喘相关性状存在正向整体遗传相关性,识别3个哮喘亚型新显著位点、5个多效性因果区域含13个基因,ERBB3为潜在核心基因,药物重定位分析提示阿那白滞素和青蒿二醇为潜在治疗候选。

要点

  • PCOS与哮喘相关性状存在正向整体遗传相关性。
  • 识别5个多效性因果区域含13个基因,ERBB3为潜在核心基因。
  • 药物重定位分析提示阿那白滞素和青蒿二醇为PCOS与哮喘共病的潜在治疗候选。

核心结论

  • 研究结果为PCOS与哮喘相关性状关联的遗传基础和生物学过程提供了新见解,值得评估PCOS特异性哮喘风险评估能否改善临床结局。

研究设计与样本

  • 研究整合UK Biobank和FinnGen队列中10 074例PCOS病例及哮喘相关性状数据。
  • 采用复合零假设下的多效性分析、遗传关联功能映射与注释、精细定位可信集分析等方法检查全局和局部遗传架构。
  • 通过药物数据库挖掘识别多效性基因作为潜在治疗靶点,并进行组织和细胞富集分析。

主要发现

  • 识别3个哮喘亚型新显著遗传位点(2个为过敏性哮喘,1个为儿童哮喘)。
  • 观察到PCOS与哮喘相关性状之间正向整体遗传相关性。
  • 发现5个多效性因果区域包含13个基因,ERBB3为贡献PCOS与哮喘相关性状共享病理生理的潜在核心基因。
  • 药物重定位分析提示阿那白滞素和青蒿二醇为PCOS与哮喘共病的潜在治疗候选。
  • 基因特异性表达连锁不平衡评分分析及转录组关联研究识别下丘脑-垂体、外分泌/内分泌、呼吸和泌尿生殖系统组织/细胞水平的基因表达模式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Observational studies have shown an association between polycystic ovary syndrome (PCOS) and asthma-related traits. However, whether this association is genetically driven or arises from observational biases remains unclear. METHODS: This study integrated data from 10 074 PCOS cases and asthma-related traits obtained from the UK Biobank and FinnGen cohorts. Global and local genetic architectures were examined using pleiotropic analysis under the composite null hypothesis, functional mapping and annotation of genetic associations, and fine-mapping credible set analysis. Drug database mining was employed to identify pleiotropic genes as potential therapeutic targets. Tissue and cell enrichment analyses were conducted to uncover shared biological mechanisms. RESULTS: We identified 3 novel significant genetic loci for asthma subtypes (2 for allergic asthma and 1 for childhood asthma). A positive overall genetic correlation between PCOS and asthma-related traits was observed. We discovered 5 pleiotropic causal regions encompassing 13 genes, with ERBB3 emerging as a potential central gene contributing to the shared pathophysiology of PCOS and asthma-related traits. Additionally, drug repositioning analysis suggested anakinra and artenimol as potential therapeutic candidates for PCOS and asthma comorbidity. The linkage disequilibrium score for the specific expression of genes analysis, along with transcriptome-wide association studies, further identified gene expression patterns at the tissue/cell level in the hypothalamo-pituitary, exocrine/endocrine, respiratory, and urogenital systems. CONCLUSION: Our findings provide novel insights into the genetic basis and biological processes underlying the association between PCOS and asthma-related traits, warranting evaluation of whether PCOS-specific asthma risk assessment could improve clinical outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ji E, Wang Z, Zhong R, et al. Genomic Correlations, Shared Loci, and Drug Targets Between Polycystic Ovary Syndrome and Asthma: Insights From Genome-wide Association Analysis. J Clin Endocrinol Metab. 2025. PMID: 40339110. doi:10.1210/clinem/dgaf276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。